Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuhei Nishiguchi

Showing results (151-160 of 303) with videos related to

Pageof 31
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2008
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter studyShinji Iwasaki, Hiromasa Ohira, Shuhei Nishiguchi, et al.
World Journal of Surgery|July 5, 2002
Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis BShoji Kubo, Kazuhiro Hirohashi, Osamu Yamazaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2008
Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C?Satoko Ohfuji, Wakaba Fukushima, Takashi Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 19, 2006
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control studySatoko Ohfuji, Wakaba Fukushima, Takashi Tanaka, et al.
World Journal of Gastroenterology|July 2, 2005
Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphyEtsushi Kawamura, Daiki Habu, Takehiro Hayashi, et al.
Hepato-Gastroenterology|March 11, 2010
Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosisDaiki Habu, Shuhei Nishiguchi, Shinji Nakatani, et al.
Gut|June 19, 2007
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis CMasao Omata, Haruhiko Yoshida, Joji Toyota, et al.
Journal of Gastroenterology|September 26, 2013
Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis CNobuhiro Aizawa, Hirayuki Enomoto, Tomoyuki Takashima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2018
Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis BMasaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.
Open Forum Infectious Diseases|November 17, 2018
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis CKentaro Matsuura, Nobuhiro Aizawa, Hirayuki Enomoto, et al.
Pageof 31

Showing results (151-160 of 303) with videos related to

Sort By:
Pageof 31
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2008
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter studyShinji Iwasaki, Hiromasa Ohira, Shuhei Nishiguchi, et al.
World Journal of Surgery|July 5, 2002
Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis BShoji Kubo, Kazuhiro Hirohashi, Osamu Yamazaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 30, 2008
Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C?Satoko Ohfuji, Wakaba Fukushima, Takashi Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 19, 2006
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control studySatoko Ohfuji, Wakaba Fukushima, Takashi Tanaka, et al.
World Journal of Gastroenterology|July 2, 2005
Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphyEtsushi Kawamura, Daiki Habu, Takehiro Hayashi, et al.
Hepato-Gastroenterology|March 11, 2010
Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosisDaiki Habu, Shuhei Nishiguchi, Shinji Nakatani, et al.
Gut|June 19, 2007
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis CMasao Omata, Haruhiko Yoshida, Joji Toyota, et al.
Journal of Gastroenterology|September 26, 2013
Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis CNobuhiro Aizawa, Hirayuki Enomoto, Tomoyuki Takashima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2018
Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis BMasaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.
Open Forum Infectious Diseases|November 17, 2018
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis CKentaro Matsuura, Nobuhiro Aizawa, Hirayuki Enomoto, et al.
Pageof 31